FDA Inspection 1089444 — Wockhardt Limited
The FDA completed an inspection of Wockhardt Limited on Apr 12, 2019 in Aurangabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 12, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Aurangabad (India)
Additional details
Clinical BA/BE